{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:15:16Z","timestamp":1793639716512,"version":"4.5.1"},"reference-count":22,"publisher":"American Diabetes Association","issue":"7","license":[{"start":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T00:00:00Z","timestamp":1595203200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.diabetesjournals.org\/content\/license"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,7,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVE<\/jats:title>\n                  <jats:p>Advances in continuous glucose monitoring (CGM) have transformed ambulatory diabetes management. Until recently, inpatient use of CGM has remained investigational, with limited data on its accuracy in the hospital setting.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                  <jats:p>To analyze the accuracy of Dexcom G6, we compared retrospective matched-pair CGM and capillary point-of-care (POC) glucose data from three inpatient CGM studies (two interventional and one observational) in general medicine and surgery patients with diabetes treated with insulin. Analysis of accuracy metrics included mean absolute relative difference (MARD), median absolute relative difference (ARD), and proportion of CGM values within 15, 20, and 30% or 15, 20, and 30 mg\/dL of POC reference values for blood glucose &amp;gt;100 mg\/dL or \u2264100 mg\/dL, respectively (% 15\/15, % 20\/20, % 30\/30). Clinical reliability was assessed with Clarke error grid (CEG) analyses.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>A total of 218 patients were included (96% with type 2 diabetes) with a mean age of 60.6 \u00b1 12 years. The overall MARD (n = 4,067 matched glucose pairs) was 12.8%, and median ARD was 10.1% (interquartile range 4.6, 17.6]. The proportions of readings meeting % 15\/15, % 20\/20, and % 30\/30 criteria were 68.7, 81.7, and 93.8%, respectively. CEG analysis showed 98.7% of all values in zones A and B. MARD and median ARD were higher in the case of hypoglycemia (&amp;lt;70 mg\/dL) and severe anemia (hemoglobin &amp;lt;7 g\/dL).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>Our results indicate that CGM technology is a reliable tool for hospital use and may help improve glucose monitoring in non\u2013critically ill hospitalized patients with diabetes.<\/jats:p>\n               <\/jats:sec>","DOI":"10.2337\/dc20-2856","type":"journal-article","created":{"date-parts":[[2021,6,7]],"date-time":"2021-06-07T18:00:11Z","timestamp":1623088811000},"page":"1641-1646","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":151,"title":["Accuracy of Dexcom G6 Continuous Glucose Monitoring in Non\u2013Critically Ill Hospitalized Patients With Diabetes"],"prefix":"10.2337","volume":"44","clinical-trial-number":[{"clinical-trial-number":"nct03877068","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03508934","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03832907","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Georgia M.","family":"Davis","sequence":"first","affiliation":[{"name":"Division of Endocrinology, Metabolism and Lipids, Department of Medicine, Emory University School of Medicine, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9352-7172","authenticated-orcid":false,"given":"Elias K.","family":"Spanakis","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Baltimore Veterans Affairs Medical Center, Baltimore, MD"},{"name":"Division of Endocrinology, Diabetes, and Nutrition, University of Maryland School of Medicine, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra L.","family":"Migdal","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Metabolism and Lipids, Department of Medicine, Emory University School of Medicine, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshmi G.","family":"Singh","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Baltimore Veterans Affairs Medical Center, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonnie","family":"Albury","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Metabolism and Lipids, Department of Medicine, Emory University School of Medicine, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Agustina","family":"Urrutia","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Metabolism and Lipids, Department of Medicine, Emory University School of Medicine, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. Walkiria","family":"Zamudio-Coronado","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Metabolism and Lipids, Department of Medicine, Emory University School of Medicine, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William H.","family":"Scott","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Baltimore Veterans Affairs Medical Center, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Doerfler","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, and Nutrition, University of Maryland School of Medicine, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Lizama","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, and Nutrition, University of Maryland School of Medicine, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Medha","family":"Satyarengga","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, and Nutrition, University of Maryland School of Medicine, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kashif","family":"Munir","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, and Nutrition, University of Maryland School of Medicine, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9295-3225","authenticated-orcid":false,"given":"Rodolfo J.","family":"Galindo","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Metabolism and Lipids, Department of Medicine, Emory University School of Medicine, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyathama","family":"Vellanki","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Metabolism and Lipids, Department of Medicine, Emory University School of Medicine, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saumeth","family":"Cardona","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Metabolism and Lipids, Department of Medicine, Emory University School of Medicine, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3845-6703","authenticated-orcid":false,"given":"Francisco J.","family":"Pasquel","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Metabolism and Lipids, Department of Medicine, Emory University School of Medicine, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limin","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3252-5026","authenticated-orcid":false,"given":"Guillermo E.","family":"Umpierrez","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Metabolism and Lipids, Department of Medicine, Emory University School of Medicine, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2021,7,20]]},"reference":[{"key":"2022051611135634800_B1","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2337\/dci19-0028","article-title":"Clinical targets for continuous glucose monitoring data interpretation: recommendations from the International Consensus on Time in Range","volume":"42","author":"Battelino","year":"2019","journal-title":"Diabetes Care"},{"key":"2022051611135634800_B2","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1177\/1932296820954163","article-title":"Continuous glucose monitors and automated insulin dosing systems in the Hospital Consensus Guideline","volume":"14","author":"Galindo","year":"2020","journal-title":"J Diabetes Sci Technol"},{"key":"2022051611135634800_B3","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ecl.2019.11.002","article-title":"Diabetes technology in the inpatient setting for management of hyperglycemia","volume":"49","author":"Davis","year":"2020","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2022051611135634800_B4","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1177\/1932296820932903","article-title":"Implementation of continuous glucose monitoring in the hospital: emergent considerations for remote glucose monitoring during the COVID-19 pandemic","volume":"14","author":"Galindo","year":"2020","journal-title":"J Diabetes Sci Technol"},{"key":"2022051611135634800_B5","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.2337\/dc20-2085","article-title":"Remote continuous glucose monitoring with a computerized insulin infusion protocol for critically ill patients in a COVID-19 medical ICU: proof of concept","volume":"44","author":"Davis","year":"2021","journal-title":"Diabetes Care"},{"key":"2022051611135634800_B6","unstructured":"Fact sheet for healthcare providers: use of Dexcom continuous monitoring systems during the COVID-19 pandemic. Accessed 28 February 2021. Available from https:\/\/www.dexcom.com\/hospitalfacts"},{"key":"2022051611135634800_B7","unstructured":"Abbott\u2019s Freestyle Libre 14 day system now available in U.S. for hospitalized patients with diabetes during COVID-19 pandemic. Accessed 28 February 2021. Available from https:\/\/abbott.mediaroom.com\/2020-04-08-Abbotts-FreeStyle-R-Libre-14-Day-System-Now-Available-in-U-S-for-Hospitalized-Patients-with-Diabetes-During-COVID-19-Pandemic"},{"key":"2022051611135634800_B8","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.2337\/dc20-1503","article-title":"Feasibility of inpatient continuous glucose monitoring during the COVID-19 pandemic: early experience","volume":"43","author":"Reutrakul","year":"2020","journal-title":"Diabetes Care"},{"key":"2022051611135634800_B9","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.2337\/dc20-0696","article-title":"Remote glucose monitoring of hospitalized, quarantined patients with diabetes and COVID-19","volume":"43","author":"Shehav-Zaltzman","year":"2020","journal-title":"Diabetes Care"},{"key":"2022051611135634800_B10","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.2337\/dci20-0046","article-title":"The impact of COVID-19 on CGM use in the hospital","volume":"43","author":"Ehrhardt","year":"2020","journal-title":"Diabetes Care"},{"key":"2022051611135634800_B11","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.2337\/dc19-2073","article-title":"Comparison of the FreeStyle Libre Pro flash continuous glucose monitoring (CGM) system and point-of-care capillary glucose testing in hospitalized patients with type 2 diabetes treated with basal-bolus insulin regimen","volume":"43","author":"Galindo","year":"2020","journal-title":"Diabetes Care"},{"key":"2022051611135634800_B12","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1177\/1932296815602905","article-title":"Continuous glucose monitoring versus capillary point-of-care testing for inpatient glycemic control in type 2 diabetes patients hospitalized in the general ward and treated with a basal bolus insulin regimen","volume":"10","author":"G\u00f3mez","year":"2015","journal-title":"J Diabetes Sci Technol"},{"key":"2022051611135634800_B13","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.2337\/dc20-0840","article-title":"Reducing inpatient gypoglycemia in the general wards using real-time continuous glucose monitoring: the glucose telemetry system, a randomized clinical trial","volume":"43","author":"Singh","year":"2020","journal-title":"Diabetes Care"},{"key":"2022051611135634800_B14","unstructured":"510 (k) Substantial Equivalence Determination Decision Summary. Accessed 1 March 2021. Available from https:\/\/www.accessdata.fda.gov\/cdrh_docs\/reviews\/K181043.pdf"},{"key":"2022051611135634800_B15","unstructured":"ACCU-CHEK Inform II blood glucose monitoring system operator\u2019s manual. Accessed 1 March 2021. Available from https:\/\/diagnostics.roche.com\/content\/dam\/diagnostics\/us\/en\/products\/a\/accu-chek-inform-ii\/toolkit\/05234646002_ACI2_OpsMan.pdf"},{"key":"2022051611135634800_B16","unstructured":"Abbott Precision XceedPro Operator\u2019s Manual\n          . Accessed 1 March 2021. Available from https:\/\/www.manualslib.com\/products\/abbott-precision-xceedpro-3551731.html"},{"key":"2022051611135634800_B17","doi-asserted-by":"crossref","first-page":"4083","DOI":"10.2337\/db13-1132","article-title":"Time lag of glucose from intravascular to interstitial compart-ment in humans","volume":"62","author":"Basu","year":"2013","journal-title":"Diabetes"},{"key":"2022051611135634800_B18","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1089\/dia.2018.0143","article-title":"Performance of a factory-calibrated real-time continuous glucose monitoring system utilizing an automated sensor applicator","volume":"20","author":"Shah","year":"2018","journal-title":"Diabetes Technol Ther"},{"key":"2022051611135634800_B19","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1177\/1932296818812062","article-title":"Measures of accuracy for continuous glucose monitoring and blood glucose monitoring devices","volume":"13","author":"Freckmann","year":"2019","journal-title":"J Diabetes Sci Technol"},{"key":"2022051611135634800_B20","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1089\/dia.2018.0142","article-title":"A new era in continuous glucose monitoring: Food and Drug Administration creates a new category of factory-calibrated nonadjunctive, interoperable class II medical devices","volume":"20","author":"Garg","year":"2018","journal-title":"Diabetes Technol Ther"},{"key":"2022051611135634800_B21","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1089\/dia.2008.0138","article-title":"Statistical tools to analyze continuous glucose monitor data","volume":"11","author":"Clarke","year":"2009","journal-title":"Diabetes Technol Ther"},{"key":"2022051611135634800_B22","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1056\/NEJM200205023461812","article-title":"Racial disparities in clinical trials","volume":"346","author":"King","year":"2002","journal-title":"N Engl J Med"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/44\/7\/1641\/633015\/dc202856.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/44\/7\/1641\/633015\/dc202856.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T11:14:58Z","timestamp":1652699698000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/44\/7\/1641\/138804\/Accuracy-of-Dexcom-G6-Continuous-Glucose"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,1]]},"references-count":22,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021,7,20]]},"published-print":{"date-parts":[[2021,7,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc20-2856","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,1]]}}}